SUNDY JOHN (Chief Medical Officer) purchased 1.8% of their position (2K shares) of PANDION THERAPEUTICS, INC. on the open market
Open‑market purchase worth $36.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/21/2020ACC: 0000899243-20-019864
Officer· Chief Medical Officer
Since Jul 2020
+147.42K
Net shares
Net buyer
$36.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
147.42K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
$18.00
Trade value
$36K
% of position
1.8%
7/21/2020
113.83K→115.83K
Total
Net shares
+2K
Net value
$36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/21/2020 | P · Purchase | +2K | $18.00 | $36K | 1.8% | 113.83K | 115.83K |
| Total | +2K | $36K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
145.42K shares
Shares
+145.42K
Strike price
18.00
Held after
145.42K
Exercisable
—
7/17/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock145.42K shares | 7/17/2020 | A · Award | +145.42K | 18.00 | — | 145.42K |